Shanghai Baisheng Biopharmaceutical

Shanghai Baisheng Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), is a specialized pharmaceutical company based in Shanghai, China. Founded in 1994, the company has established itself as a key manufacturer of high-quality chemical drug formulations, particularly in the cardiovascular, anti-infective, and digestive system therapeutic areas. Its flagship products include Amlodipine Besylate (marketed as Yaxitong) for hypertension and various antibiotics such as Cefaclor and Clarithromycin. The company operates advanced, GMP-certified manufacturing facilities in the Pudong New Area and is recognized as a High-Tech Enterprise by the Shanghai municipal government. By leveraging the extensive research and distribution capabilities of its parent company, SPH, Shanghai Baisheng maintains a significant market presence across mainland China.